Home › Stocks › SABS › All Fund Holders
SABS — SAB BIOTHERAPEUTICS INC · All Fund Holders
Funds holding (latest): 27 · Reported value held: $57.56M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Balyasny Asset Management history | Q2 2026 | 3.76M | $14.67M | 0.02% | Hold |
| BlackRock Inc history | Q2 2026 | 3.07M | $11.96M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 2.75M | $10.72M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 1.85M | $6.91M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.28M | $4.98M | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 463.93K | $1.78M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 365.88K | $1.43M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 362.49K | $1.41M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 214.63K | $837.07K | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 191.31K | $746.09K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 107.85K | $420.60K | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 105.68K | $412.16K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 62.80K | $244.91K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 44.08K | $171.92K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 42.37K | $165.25K | 0.00% | New |
| Renaissance Technologies history | Q3 2025 | 80.84K | $162.49K | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 26.58K | $103.68K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 25.13K | $97.99K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 22.59K | $88.11K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 18.09K | $70.55K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 13.75K | $53.62K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 12.95K | $50.49K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 10.27K | $40.05K | 0.00% | Add |
| Prudential Financial history | Q2 2023 | 36.20K | $30.05K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 4.22K | $16.47K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 116 | $452 | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 35.62K | $139 | 0.00% | New |